| scholarly article | Q13442814 |
| P50 | author | Asude Aksoy | Q60327393 |
| Mustafa Değirmenci | Q98770903 | ||
| P2093 | author name string | Mahmut Gumus | |
| Nilufer Avci | |||
| Oktay Bozkurt | |||
| Yalcin Cirak | |||
| Havva Y Cinkir | |||
| Hatice Odabas | |||
| Yakup Bozkaya | |||
| Serap Kaya | |||
| Aydin Aytekin | |||
| Erkan Arpaci | |||
| Kezban N Pilanci | |||
| Turkan O Topcu | |||
| P2860 | cites work | Breast cancer in the young: role of the geneticist | Q36963403 |
| Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database | Q37225635 | ||
| Genomic Biomarkers for Breast Cancer Risk | Q37242239 | ||
| Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma. | Q37484662 | ||
| Clinicopathologic features of triple negative breast cancers: an experience from Pakistan. | Q37717271 | ||
| ASCO-CAP guidelines for breast predictive factor testing: an update | Q37956940 | ||
| Histological and immunohistochemical features of medullary breast cancer | Q40029316 | ||
| Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer | Q41671579 | ||
| The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast | Q42450895 | ||
| Spontaneous regression of a conjunctival malignant melanoma | Q43461981 | ||
| Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up | Q44770600 | ||
| Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome. | Q45913858 | ||
| Medullary carcinoma of the breast: a brief report from a tertiary care center. | Q46080058 | ||
| Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. | Q50665044 | ||
| Breast cancer in very young women. | Q51411300 | ||
| Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less. | Q54321406 | ||
| [Medullary carcinoma experience in breast oncology unit of Hospital Juarez Mexico] | Q86296531 | ||
| Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)† | Q27027579 | ||
| CD317 Promotes the survival of cancer cells through apoptosis-inducing factor | Q27468925 | ||
| A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition | Q28305715 | ||
| Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base | Q31113537 | ||
| Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases | Q34465749 | ||
| Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study | Q35743495 | ||
| Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population | Q35840060 | ||
| Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas | Q35984157 | ||
| Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers | Q36099968 | ||
| High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients | Q36110709 | ||
| Spontaneous regression of plasmablastic lymphoma in an elderly human immunodeficiency virus (HIV)-negative patient | Q36131098 | ||
| Medullary carcinoma of the breast: a population-based perspective. | Q36132942 | ||
| Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy | Q36228539 | ||
| Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials | Q36337755 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified | Q36803533 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 156-162 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Saudi Medical Journal | Q15755333 |
| P1476 | title | Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort | |
| P478 | volume | 38 |
Search more.